Medical News
Study reveals a cause of poorer outcomes for African-American patients with breast cancer
e! Science News - 19 Apr 2015 20:22
Poorer outcomes for African-American women with estrogen-receptor positive (ER+) breast cancer, compared with European-American patients, appears to be due, in part, to a strong survival mechanism within the cancer cells...
Pembrolizumab versus Ipilimumab in Advanced Melanoma
New England Journal of Medicine - 19 Apr 2015 14:30
New England Journal of Medicine, Ahead of Print.
Court Favors Pfizer In Zoloft-Birth Defect Case
Tech Times - 19 Apr 2015 12:43
Pfizer is cleared of liability concerning allegations that its antidepressant Zoloft had caused birth defects in a boy in California, according to a St. Louis court.
Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients
EurekAlert! - 19 Apr 2015 06:00
(University of Pennsylvania School of Medicine) The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form...
Broccoli sprout extract promising for head and neck cancer prevention
EurekAlert! - 19 Apr 2015 06:00
(University of Pittsburgh Schools of the Health Sciences) Broccoli sprout extract protects against oral cancer in mice and proved tolerable in a small group of healthy human volunteers, the University of Pittsburgh Cance...
The Lancet Infectious Diseases: Leading doctors warn that sepsis deaths will not be curbed without radical rethink of research strategy
EurekAlert! - 19 Apr 2015 06:00
(The Lancet) Leading doctors today warn that medical and public recognition of sepsis -- thought to contribute to between a third and a half of all hospital deaths -- must improve if the number of deaths from this common...
Seeking new targets for ovarian cancer treatment
EurekAlert! - 19 Apr 2015 06:00
(University of Pittsburgh Schools of the Health Sciences) Identifying molecular changes that occur in tissue after chemotherapy could be crucial in advancing treatments for ovarian cancer, according to research from Mage...
Investigational personalized cellular therapy tolerated well by patients
EurekAlert! - 19 Apr 2015 06:00
(University of Pennsylvania School of Medicine) Genetically modified versions of patients' own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancre...
New combo of immunotherapy drugs is safe, shrinks tumors in metastatic melanoma patients
EurekAlert! - 19 Apr 2015 06:00
(University of Pennsylvania School of Medicine) Once again, researchers at Penn's Abramson Cancer Center have extended the reach of the immune system in the fight against metastatic melanoma, this time by combining the c...